IRIS
SAMPAOLESI, MAURILIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.045
AS - Asia 4.741
EU - Europa 3.949
SA - Sud America 665
AF - Africa 89
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 15.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.940
CN - Cina 2.736
SG - Singapore 1.009
IE - Irlanda 1.007
UA - Ucraina 616
BR - Brasile 540
HK - Hong Kong 507
FI - Finlandia 486
DE - Germania 447
RU - Federazione Russa 401
IT - Italia 247
VN - Vietnam 231
GB - Regno Unito 221
SE - Svezia 208
BE - Belgio 93
FR - Francia 89
IN - India 63
CA - Canada 60
AR - Argentina 45
MX - Messico 37
BD - Bangladesh 28
ZA - Sudafrica 28
EC - Ecuador 25
IQ - Iraq 25
PL - Polonia 25
NL - Olanda 23
TR - Turchia 21
ES - Italia 16
ID - Indonesia 15
AU - Australia 13
JP - Giappone 13
VE - Venezuela 13
CZ - Repubblica Ceca 12
KE - Kenya 12
MA - Marocco 12
AE - Emirati Arabi Uniti 10
EG - Egitto 10
PY - Paraguay 10
IR - Iran 9
LT - Lituania 9
SA - Arabia Saudita 9
TN - Tunisia 9
UZ - Uzbekistan 9
CL - Cile 8
CO - Colombia 8
EU - Europa 8
PK - Pakistan 8
JO - Giordania 7
AT - Austria 6
UY - Uruguay 6
AZ - Azerbaigian 5
CH - Svizzera 5
KZ - Kazakistan 5
PE - Perù 5
RO - Romania 5
DZ - Algeria 4
EE - Estonia 4
GR - Grecia 4
KR - Corea 4
MU - Mauritius 4
SN - Senegal 4
TH - Thailandia 4
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
GE - Georgia 3
KG - Kirghizistan 3
LV - Lettonia 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
LB - Libano 2
MN - Mongolia 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BB - Barbados 1
CD - Congo 1
CR - Costa Rica 1
GF - Guiana Francese 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PG - Papua Nuova Guinea 1
Totale 15.508
Salva come PNG Salva come JPEG
Città #
Dublin 1.007
Chandler 938
Jacksonville 786
Nanjing 642
Hong Kong 505
Ashburn 494
Singapore 480
Dallas 397
Beijing 359
Boardman 339
Nanchang 270
Princeton 215
Lawrence 209
Medford 203
Wilmington 198
Hebei 196
Shenyang 180
Changsha 162
Ann Arbor 157
Jiaxing 157
Los Angeles 157
Helsinki 134
Hangzhou 110
Tianjin 106
Buffalo 91
Ho Chi Minh City 86
Milan 81
Munich 67
Moscow 63
Shanghai 63
Woodbridge 62
Redondo Beach 60
Pavia 54
Verona 51
New York 47
Hanoi 42
Brussels 40
São Paulo 40
Herent 33
Norwalk 31
Turku 29
Seattle 28
Fairfield 26
Guangzhou 26
Toronto 24
Brooklyn 23
Kunming 23
The Dalles 23
Warsaw 23
Johannesburg 22
Pune 21
Falkenstein 20
Leuven 20
Washington 20
Chicago 19
Des Moines 19
Houston 19
Montreal 19
San Francisco 17
Santa Clara 17
Auburn Hills 15
Jinan 15
Baghdad 14
Chennai 14
Falls Church 14
Poplar 14
Rio de Janeiro 14
Brasília 13
Denver 13
Phoenix 13
Zhengzhou 13
Belo Horizonte 12
Boston 12
Nuremberg 12
Stockholm 12
Tokyo 12
Ankara 11
London 11
Mexico City 11
Ningbo 11
Redwood City 11
Dearborn 10
Nairobi 10
Orem 10
Porto Alegre 10
Atlanta 9
Biên Hòa 9
Columbus 9
Taizhou 9
Tashkent 9
Brno 8
Da Nang 8
Guayaquil 8
Haiphong 8
Lanzhou 8
Manchester 8
Quito 8
Quảng Ngãi 8
Santo André 8
Amman 7
Totale 10.181
Salva come PNG Salva come JPEG
Nome #
Alpha sarcoglycan is required for FGF dependent myogenic progenitor cell proliferation in vitro and in vivo. 149
Evaluation of energy expenditure in athletes practising horseback riding 149
Adult Stem Cells And Tissue Engineering In Osteogenic Differentiation: Valutation Of The Binomial Bioreactor-Scaffold. 148
Characterization Of Cardiac Progenitors From Murine Dystrophic Heart. 144
Analysis of the effect of high frequency vibrations on Saos-2 human osteoblasts in bone tissue engineering. 141
ELECTROMAGNETIC FIELDS INFLUENCE GENE EXPRESION OF SAOS-2 CELL LINE 139
A BIOCHEMICAL AND MOLECULAR STUDY OF STEM CELL ADHESION AND DIFFERENTIATIONON POSITIVELY CHARGED SURFACES 139
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis. 135
Electromagnetic fields influence the gene expression of SAOS-2 cell line 135
GENE EXPRESSION PROFILE IN MAGIC-F1 MYOGENIC PROGENITORS 133
HGF-RELATED PROTEIN INDUCES MUSCLE HYPERTROPHY BOTH IN VITRO AND IN VIVO. 131
Folic Acid Exposure Rescues Spina Bifida Aperta Phenotypes in Human Induced Pluripotent Stem Cell Model 131
In vitro adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 130
Improved adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 129
Tissue engineering of the bone: biomaterials and electromagnetic influence on SAOS-2 differentiation 111
Binding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two molecules. 109
Analysis of the molecular mechanism of sarcoglycanopathy: a new approach of gene therapy of limb-girdle and Duchenne-like dystrophy (TF 463/bi) 109
Magic Factor-1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis 108
Adult Stem Cells and Skeletal Muscle Regeneration 108
Tissue engineering of bone: biomaterials and electromagnetic influence on SAOS2 differentiation 107
Abnormal calcium homeostasis and cell damage in dystrophic myotubes 107
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients 106
Cell therapy strategies and improvements for muscular dystrophy. 105
Autologous micrograft accelerates endogenous wound healing response through ERK-induced cell migration 104
Impairment Of Cardiac Progenitor Diferentiation In The Murine Dystrophic Heart. 103
Altered functional differentiation of mesoangioblasts in a genetic myopathy. 103
Role of miRNAs in Muscle Stem Cell Biology: Proliferation, Differentiation and Death. 102
Bedside to bench: a look at experimental research with a clinical trial checklist 102
Amniotic stem cells reprogramming for tissue regeneration in animal model prenatal myelomeningocele repair. 102
Cardiac mesangioblasts are committed, self renewable progenitors, associated in small vessel of both adult normal and cardiomyopathic mouse ventricle 101
Gene signature of muscle hypertrophy 101
Met-Activating Genetically Improved Chimeric Factor-1 Promotes Angiogenesis and Hypertrophy in Adult Myogenesis 100
Cardiac dystrophic mesoangioblasts molecular characterization of in vitro and in vivo differentiation. 100
Aging affects the in vivo regenerative potential of human mesoangioblasts 97
Magic Factor-1: a new engineered protein involved in muscular hypertrophy and regeneration 97
Valutation Of The Binomial Bioreactor-Scaffold In Osteogenic Differentiation Of Adult Stem Cells. 93
Brief Communication Arising 93
About Mesoangioblasts 93
HGF-derived recombinant protein M.A.G.I.C F1: a novel approach to induce muscular hypertrophy 93
ROLE OF HUMAN SIALIDASES IN THE DIFFERENTIATION OF NORMAL AND PHATOLOGICAL SKELETAL MUSCLE TISSUE 93
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors 93
Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. 92
Atrial natriuretic factor (ANF) and ANF receptor C gene expression and localization in the respiratory system: effects induced by hypoxia and hemodynamic overload. 92
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. 91
Magic F1 hypertropic factor to enhance myogenesis on polyesterurethane scaffolds 91
Poly-l-Lactic Acid Nanofiber–Polyamidoamine Hydrogel Composites: Preparation, Properties, and Preliminary Evaluation as Scaffolds for Human Pluripotent Stem Cell Culturing 90
In vitro and in vivo tissue engineering approaches in regenerative medicine 90
Molecular imaging of human embryonic stem cells stably expressing human PET reporter genes after zinc finger nuclease-mediated genome editing 90
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. 89
Alteration of cardiac progenitor cell potency in GRMD dogs 89
Evaluation of the effects of a dynamic culture on osteogenic differentiation of oral-periosteal cells grown on PLGA sponges 89
The effects of micro-grafts in the treatment of androgenetic alopecia 88
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra- Arterial Delivery of Mesoangioblasts 87
HGF-DERIVED RECOMBINANT PROTEIN SELECTIVELY ACTIVATES THE AKT PATHWAY AND INDUCES MUSCLE HYPERTROPHY 87
Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype. 86
Inducing muscular hypertrophy by recombinant proteins 86
Magic F-1: a new engineered protein involved in muscular hypertrophy and regeneration 85
Activin A Modulates CRIPTO-1/HNF4α+ Cells to Guide Cardiac Differentiation from Human Embryonic Stem Cells 85
MmNEU3 sialidase over-expression in C2C12 myoblasts delays differentiation and induces hypertrophic myotube formation 84
Skeletal muscle engineering: scaffolds and recombinant proteins 84
HGF-DERIVED RECOMBINANT PROTEIN M.A.G.I.C. F1: A NOVEL APPROACH TO INDUCE MUSCULAR HYPERTROPHY 82
Myoblast 3D bioprinting to burst in vitro skeletal muscle differentiation 82
Cell therapy of muscular dystrophy by mesoangioblasts grafting in the dystrophic dogs 81
Hamster cardiomyocytes: a model of myocardial regeneration? 81
In Vivo Engrafment Of Cardiac Dystrophic Mesoangioblasts. 80
Intramuscular injection of human circulating AC133 positive cells ameliorates the function of scid/mdx dystrophic single muscle fibres 80
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 80
Cardiac development and remodelling in Magic-F1 transgenic mice 80
The mesmiRizing complexity of microRNAs for striated muscle tissue engineering 79
Activator Protein-1 Transcriptional Activity Drives Soluble Micrograft-Mediated Cell Migration and Promotes the Matrix Remodeling Machinery 79
Cardiac dystrphic mesoangioblasts: Molecular characterization of in vitro and in vivo differentiation 78
Welcome to Cardiovascular Research in 2015 78
Stem cells for the treatment of Muscular Dystrophy: more than a wishful thinking? 78
Magic-F1 transgene cooperates with Pax 3 during early myogenesis to induce muscular hypertrophy 78
Muscle hypertrophy and vascularization induction using recombinant proteins 78
Lentiviral vector gene transfer is limited by the proteasome at postentry steps in various types of stem cells. 77
Fate choice of post-natal mesoderm progenitors: skeletal versus cardiac muscle plasticity. 77
Terapia cellulare mesenchimale nella distrofia muscolare 77
Increased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell Imaging 77
(Epi)genetic Modifications in Myogenic Stem Cells: From Novel Insights to Therapeutic Perspectives 77
Preclinical trial of mesoangioblast grafting in the Golden Retriever Muscular Dystrophy 76
Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. 76
Tuning multi/pluri-potent stem cell fate by electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nanocomposite mats 76
Mononucleated Cells to Regenerate Skeletal Muscle Syncytial Tissues 76
Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions 76
Unconventional Players on the Striated Muscle Field: MicroRNAs, Signaling Pathways and Epigenetic Regulators 75
Mesoangioblast Transplantation as a Cell Therapy for Muscular Dystrophy 75
New therapies for muscular dystrophy: cautious optimism. 75
Stem Cell homing and regulation: new insights from muscular dystrophy 75
In vitro osteoblastic differentiation of human mesenchymal stem cells and human dental pulp stem cells on poly-L-lysine-treated titanium-6-aluminium-4-vanadium 75
Noggin inactivation affects the number and differentiation potential of muscle progenitor cells in vivo 75
Stem cell therapy in muscular dystrophiesStem cell and small RNAs as tools for basic science and regenerative medicine 74
Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature. 74
Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. 73
MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitors 73
Mouse, dog and human mesoangioblasts 72
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability 72
Human postnatal dental pulp cells co-differentiate into osteoblasts and endotheliocytes: a pivotal synergy leading to adult bone tissue formation. 72
Stem cell-niche and lysosomal cathepsins 72
Mouse and human mesoangioblasts: isolation and characterization from adult skeletal muscles. 72
Totale 9.411
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.762
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021780 0 0 0 0 0 145 14 203 60 176 142 40
2021/2022860 19 6 19 9 14 13 17 53 57 15 135 503
2022/20232.805 358 174 32 226 280 275 0 167 1.170 14 73 36
2023/2024907 115 153 36 76 117 241 12 48 4 24 14 67
2024/20252.473 38 242 116 78 40 87 125 170 559 71 287 660
2025/20263.366 473 485 757 748 695 208 0 0 0 0 0 0
Totale 15.759